Vaccines, COVID-19, and Myeloma with Dr. Mike Thompson

Name: Vaccines, COVID-19, and Myeloma with Dr. Mike Thompson
Start: 2021-04-07T16:00:00-04:00
End: 2021-04-07T17:00:00-04:00

Vaccines, COVID-19, and Myeloma with Dr. Mike Thompson

Webinar

Apr 07, 2021 / 04:00PM - 05:00PM EDT

Event Description

With new COVID-19 vaccinations, many of us within the Myeloma Community have questions about how it will affect us. Come hear from an expert, Dr. Mike Thompson, as he presents on infections, vaccines, and antibiotics for myeloma patients, then take the opportunity to ask Dr. Thompson any questions you may have.

Schedule & Agenda

04:00 PM

Introductions

Audrey Burton-Bethke

Audrey introduces our featured speaker, Dr. Mike Thompson, and the event agenda.

04:00 PM

Introductions

Audrey Burton-Bethke

Audrey introduces our featured speaker, Dr. Mike Thompson, and the event agenda.

04:05 PM

Presentation

Dr. Mike Thompson

Dr. Thompson presents on infections, vaccines, and antibiotics for myeloma patients.

04:05 PM

Presentation

Dr. Mike Thompson

Dr. Thompson presents on infections, vaccines, and antibiotics for myeloma patients.

04:45 PM

Q&A

Audience

Dr. Thompson answers the audience's questions about his presentation and related topics.

04:45 PM

Q&A

Audience

Dr. Thompson answers the audience's questions about his presentation and related topics.

Speakers & Moderators

Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.

Read Bio

Michael A. Thompson, MD, Ph.D.

Michael A. Thompson, MD, Ph.D. is the Medical Director for the Early Phase Cancer Research Program, Patient-Centered Research at the Aurora Research Institute. He is an active clinical researcher whose interests include hematologic or blood cancers (lymphoma, myeloma, leukemia, and myelodysplastic syndrome). He is also interested in developing new treatments for all cancers, particularly early phase (Phase I and II) molecular biomarker-driven clinical trials. In addition, he is extensively published and serves as a reviewer for multiple scientific publications.

Read Bio

Join the Conversation

This event is part of the Treatments & Drugs group in HealthTree Connect, a social media platform for people with blood cancer. If you want to connect with other patients and caregivers and talk about this topic, join HealthTree Connect.